Clinical trial
A Clinical Study of GP73 as a HCC Early Tumor Mark
NCT00902902 is registered in ClinicalTrials.gov with Peking Union Medical College Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Clinical Study of GP73 as a HCC Early Tumor Mark
- Lead sponsor
- Peking Union Medical College Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- January 31, 2008
- Completion date
- July 31, 2009
- Enrollment
- 0 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hepatocellular carcinoma